Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chau

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and HopesIan Chau
Expert Opinion on Biological Therapy|July 14, 2016
Immunotherapy for oesophagogastric cancerMichael Davidson, Ian Chau
Drugs|December 2, 2015
Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future DirectionsKate Young, Ian Chau
Expert Review of Anticancer Therapy|February 13, 2018
Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approachesMichael Davidson, Ian Chau
Cancer Treatment Reviews|January 23, 2025
Claudins as diagnostic tools and therapeutic targets-Glimpse of the horizonKeiji Sugiyama, Ian Chau
Expert Opinion on Investigational Drugs|June 21, 2016
Novel STAT 3 inhibitors for treating gastric cancerCatherine Cafferkey, Ian Chau
Expert Opinion on Investigational Drugs|January 17, 2022
Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trialsHazel Lote, Ian Chau
Hematology/Oncology Clinics of North America|May 15, 2017
Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric AdenocarcinomaGayathri Anandappa, Ian Chau
Expert Opinion on Investigational Drugs|December 15, 2010
Patupilone in cancer treatmentBranislav Bystricky, Ian Chau
Future Oncology (London, England)|January 16, 2019
Ramucirumab and its use in the treatment of hepatocellular carcinomaFiona Turkes, Ian Chau
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and HopesIan Chau
Expert Opinion on Biological Therapy|July 14, 2016
Immunotherapy for oesophagogastric cancerMichael Davidson, Ian Chau
Drugs|December 2, 2015
Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future DirectionsKate Young, Ian Chau
Expert Review of Anticancer Therapy|February 13, 2018
Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approachesMichael Davidson, Ian Chau
Cancer Treatment Reviews|January 23, 2025
Claudins as diagnostic tools and therapeutic targets-Glimpse of the horizonKeiji Sugiyama, Ian Chau
Expert Opinion on Investigational Drugs|June 21, 2016
Novel STAT 3 inhibitors for treating gastric cancerCatherine Cafferkey, Ian Chau
Expert Opinion on Investigational Drugs|January 17, 2022
Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trialsHazel Lote, Ian Chau
Hematology/Oncology Clinics of North America|May 15, 2017
Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric AdenocarcinomaGayathri Anandappa, Ian Chau
Expert Opinion on Investigational Drugs|December 15, 2010
Patupilone in cancer treatmentBranislav Bystricky, Ian Chau
Future Oncology (London, England)|January 16, 2019
Ramucirumab and its use in the treatment of hepatocellular carcinomaFiona Turkes, Ian Chau
Pageof 27